Home > Boards > US Listed > Medical - Drugs >

Spectrum Pharmaceutecals, Inc. (SPPI)

SPPI RSS Feed
Add SPPI Price Alert      Hide Sticky   Hide Intro
Moderator: antihama
Search This Board: 
Last Post: 10/23/2019 6:11:03 PM - Followers: 84 - Board type: Free - Posts Today: 1

http://www.spectrumpharm.com/

- Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung Cancer (NSCLC) Presented at the 18th IASLC World Conference on Lung Cancer in Japan  - PR

http://investor.sppirx.com/releasedetail.cfm?ReleaseID=1044288
 

- 18th IASLC World Conference on Lung Cancer: Poziotinib Update - Conference Call 

https://edge.media-server.com/m6/p/4r5me9dd

.  

 

SPPI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPPI News: Spectrum Pharmaceuticals Announces Publication of Positive Poziotinib Data in Cancer Cell 10/04/2019 07:00:00 AM
SPPI News: Spectrum Pharmaceuticals to Present Corporate Update at the 2019 Cantor Global Healthcare Conference on October 2nd 09/25/2019 07:00:00 AM
SPPI News: Spectrum Announces Poziotinib Data Being Presented at the IASLC 2019 World Conference on Lung Cancer 09/06/2019 04:30:00 PM
SPPI News: Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September 09/03/2019 07:00:00 AM
SPPI News: Statement of Changes in Beneficial Ownership (4) 08/12/2019 06:52:46 PM
PostSubject
#2678   Reason Why Dr Heymach took a step back antihama 10/23/19 06:11:03 PM
#2677   While a TDM-1 Pozi Combo trial bodes well antihama 10/18/19 08:31:26 AM
#2676   Non-Pozi Combo trial This Year Silver Lining Conjecture. antihama 10/17/19 12:48:29 PM
#2675   “We didn’t want any analysis done until there’s antihama 10/16/19 07:39:39 AM
#2674   6m after last patient was dosed was ~July antihama 10/15/19 12:08:10 PM
#2673   Reading about the current vincristine shortage; Marqibo (Vincristine antihama 10/15/19 11:46:18 AM
#2672   Clarification; each of the passages should have been antihama 10/13/19 11:26:04 AM
#2671   RE:Publication of Positive Poziotinib Data in Cancer Cell excerpts antihama 10/10/19 08:19:03 PM
#2670   Publication of Positive Poziotinib Data in Cancer Cell antihama 10/04/19 11:08:57 AM
#2669   Does the conservative approach bode well for pozi antihama 10/03/19 10:05:42 AM
#2668   A Zenith20 nugget from Cantor Global HCC's CC antihama 10/03/19 07:01:35 AM
#2667   Several take homes from the Cantor Global HCC antihama 10/02/19 07:43:18 PM
#2666   Welcome whytestocks. The clock starts ticking from Oct antihama 09/25/19 02:06:49 PM
#2665   News: $SPPI Spectrum Pharmaceuticals to Present Corporate Update whytestocks 09/25/19 01:30:19 PM
#2664   After re-listening to the last part of the antihama 09/13/19 05:34:05 PM
#2663   OMG! Did no one pick up on what antihama 09/13/19 12:14:47 PM
#2662   New Sept Presentation updated from July, is the antihama 09/13/19 11:08:37 AM
#2661   Posi’s a WINNER for Exon 18 atypical P-loop antihama 09/07/19 07:27:42 AM
#2660   IASLC P1.14-08 - Activity of Poziotinib and Other antihama 09/06/19 05:31:41 PM
#2659   Spectrum Presenting at Two Investor Conferences; September 10th antihama 09/03/19 06:45:54 PM
#2658   Yeah, I remember those MEDX days. Advanced degree s antihama 08/26/19 06:24:40 PM
#2657   I will feel guilty if I won't praise ttp22 08/26/19 03:57:19 PM
#2656   Thanks PenPen24. Why does Arlo Guthrie's "Alice's Restaurant" antihama 08/26/19 01:28:08 PM
#2655   Antihama, like BarrellofHay said, please keep posting! I PenPen24 08/26/19 08:27:31 AM
#2654   OS SoC for 1st-line and Relapsed/refractory patients was antihama 08/22/19 10:25:30 PM
#2653   RE: Pozi EGFRex20 SoC competition. antihama 08/22/19 09:49:50 PM
#2652   Sure thing!! I am still getting up to BarrellofHay 08/22/19 09:15:40 PM
#2651   RE: Comparing TAK-788 and Pozi’s most recent data. antihama 08/22/19 08:16:37 PM
#2650   Thanks BarrellofHay for the encouragement. antihama 08/22/19 07:57:28 AM
#2649   Hi Antihama!! Please keep up the great work BarrellofHay 08/21/19 11:09:41 PM
#2648   40% of total pharma deals involve Kinase Inhibitors antihama 08/21/19 05:24:17 PM
#2647   Per Elle Investments, Spectrum's an asymmetric risk/reward stock! antihama 08/20/19 11:32:27 AM
#2646   "Behind The Idea: Spectrum Pharma-Great Asset" SA article antihama 08/20/19 11:05:18 AM
#2645   Hey, JT, take a cue from CASI’s CEO antihama 08/16/19 10:52:37 AM
#2644   Discussion on Precision Medicine's from Xconomy antihama 08/15/19 11:12:06 AM
#2643   Well, one week later I'm posting again. I antihama 08/15/19 10:52:19 AM
#2642   I know, I know antihama 08/11/19 10:04:20 PM
#2641   I'm so annoyed about this that I sent antihama 08/08/19 11:48:10 AM
#2640   Spectrum needs to explain why no interim data antihama 08/08/19 11:17:22 AM
#2639   Quarterly CC; an explanation on pozi interim data antihama 08/07/19 11:18:20 AM
#2638   And another thing about Zenith 20 cohort 5. antihama 07/25/19 04:09:31 PM
#2637   Is the Zenith20 1st-line EGFR cohort fully recruited? antihama 07/25/19 03:56:11 PM
#2636   I just don't get it! JT and his bsweet8 07/25/19 02:52:29 PM
#2635   Ha, Ha! Analyst Recommendation; from Sell to Hold antihama 07/25/19 07:25:14 AM
#2634   Ha! Pozi’s a Coming Right at Ya! antihama 07/23/19 08:08:28 AM
#2632   NGS fast becoming part of Standard of Care (SOC) antihama 07/18/19 08:50:12 PM
#2631   Perhaps you think B Riley doesn’t give downgrades antihama 07/16/19 10:29:10 AM
#2630   RE:Oppenheimer 29th Annual Healthcare Conference CC antihama 07/15/19 02:11:11 PM
#2629   Rolontis' Good Supplier Management Practices. antihama 07/12/19 11:16:55 AM
#2628   PS UDENYCA has a 36-month shelf life so antihama 07/11/19 05:26:06 PM
PostSubject